secwatch.observer — SEC 8-K summary
======================================

Issuer:     Hepion Pharmaceuticals, Inc. (HEPA)
CIK:        0001583771
Form:       8-K
Filed at:   2026-09-08T21:24:25+00:00
Accession:  0001493152-26-041801
Event type: debt
Sentiment:  neutral
Materiality: 0.40
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hepion Pharmaceuticals issues $500K secured convertible note to Gravitas Capital
--------------------------------------------------------------------------------

- $500,000 secured convertible note with 8% paid-in-kind interest, maturing Sept 3, 2027.
- Note convertible at $0.04/share, contingent on stockholder approval to increase authorized shares.
- Warrant to buy 12.5M common shares at $0.06, exercisable until Sept 3, 2031.
- Note secured by all company assets; sale is unregistered under Regulation D/4(a)(2).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226041801/0001493152-26-041801-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1583771/000149315226041801/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-26-041801

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer